510(k) K092274

RANDOX BENZODIAZEPINE ASSAY by Randox Laboratories, Ltd. — Product Code JXM

K092274 is an FDA 510(k) premarket notification submitted by Randox Laboratories, Ltd. for the device "RANDOX BENZODIAZEPINE ASSAY". The FDA issued a decision of Substantially Equivalent on Oct 15, 2010. The device falls under product code JXM (Enzyme Immunoassay, Benzodiazepine), a Class II device regulated under 21 CFR 862.3170. Randox Laboratories, Ltd. has 115 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 15, 2010
Date Received
Jul 28, 2009
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Immunoassay, Benzodiazepine
Device Class
Class II
Regulation Number
862.3170
Review Panel
TX
Submission Type
510(k)

Need the full FDA record for Randox Laboratories, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K092274. Report a data issue: hello@regdatalab.com.